Divi's Laboratories Q2 Results FY27: PAT Rises 65.46% to Rs 1,140 Cr, Revenue Rs 3,647 Cr

Divi's Laboratories Ltd (DIVISLAB) Q2 Results FY27 announced on 7 November 2026, covering the company's financial performance for the July to September quarter. The results date brought revenue of Rs 3,647 Cr and net profit (PAT) of Rs 1,140 Cr. Divi's Laboratories Q2 Results FY27 are compared with the same quarter a year earlier.

Divi's Laboratories Q2 Results are covered here through a results analysis of the financial highlights, business drivers, outlook and risks. Univest has set this quarter against the same quarter of last year, and the Financial Highlights table that follows carries those figures side by side.

Click Here – Get Free Investment Predictions

Divi's Laboratories Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 3647 Cr	Rs 2715 Cr	+34.33% YoY
Net Profit (PAT)	Rs 1140 Cr	Rs 689 Cr	+65.46% YoY

Source: company filing for Divi's Laboratories Q2 Results FY27, 7 November 2026. Figures in Rs Crore.

Key Takeaways from Divi's Laboratories Q2 Results: What Stands Out

• Revenue Rs 3,647 Cr: up from Rs 2,715 Cr a year earlier, which is YoY growth of 34.33% in the July to September 2026 quarter.
• Net profit Rs 1,140 Cr: compared with Rs 689 Cr in the same quarter last year, a rise of 65.46%.
• Net profit margin 31.3%: up from 25.4% in the comparison quarter, because net profit grew faster than revenue.
• Divi's Laboratories Q2 Results FY27: declared on 7 November 2026, with return on equity of 16.19% in FY26.
• Risk headline: a single quarter does not set a trend, and the performance analysis below shows where this quarter sits.

Divi's Laboratories Q2 Results FY27: Performance Analysis

Divi's Laboratories Q2 Results FY27 show revenue rising 34.33% YoY to Rs 3,647 Cr, while net profit rose 65.46% to Rs 1,140 Cr. Net profit therefore grew at almost twice the pace of revenue in this quarter.

In Divi's Laboratories Q2 Results, the quarterly results add Rs 932 Cr of revenue over the Rs 2,715 Cr reported a year earlier, and net profit is Rs 451 Cr higher than Rs 689 Cr. This results analysis uses simple differences, so every figure traces back to the supplied numbers.

Investors following Divi's Laboratories Q2 Results FY27 will watch whether YoY growth in revenue and net profit carries into later disclosures, since a single quarter does not set a trend. Margin and returns sit behind the figures, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points to three business factors, and the first is revenue, which grew 34.3% year on year to Rs 3,647 Cr in the latest quarter. That expansion forms the base on which the rest of the quarterly results are built.

Net Profit Growth – Net profit rose 65.5% year on year to Rs 1,140 Cr, the second business factor in Divi's Laboratories Q2 Results FY27, which means profit grew faster than revenue over the year-ago quarter.

Net Profit Margin And Return on Equity – Net profit margin improved to 31.3% from 25.4% in the comparison quarter, and return on equity was 16.19% in FY26. Together these form the third factor, a margin figure for the quarter and a full-year return figure beside it.

FY27 Outlook After Divi's Laboratories Q2 Results

FY27 full-year results will depend on subsequent quarters and on disclosed sector conditions. The net profit of Rs 1,140 Cr in this quarter is one data point, and Divi's Laboratories Q2 Results FY27 should be read as part of a longer sequence of filings through the year.

A fuller results analysis becomes possible as later quarters are declared, because each filing adds a new comparison. Investors can use the Univest Screener to follow those filings and track net profit over time, and the risks that follow are the next item to weigh.

Key Risks to Watch After Divi's Laboratories Q2 Results FY27

Single Quarter Reading

Divi's Laboratories Q2 Results FY27 describe one quarter. A single quarter of YoY growth does not set a trend, so later filings will show whether Rs 1,140 Cr of net profit repeats.

Return Reference Is Annual

Return on equity of 16.19% is an FY26 full-year figure, so it does not measure the July to September 2026 quarter. Investors can compare it with later annual figures when new balance sheets are published.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Divi's Laboratories Q2 Results FY27 show revenue of Rs 3,647 Cr and net profit of Rs 1,140 Cr, both higher than a year earlier. These quarterly results are best read with the FY26 return figure listed above and can be tracked on the Univest app. In short, Divi's Laboratories Q2 Results carry no advice, so investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Divi's Laboratories Q2 Results FY27

What are Divi's Laboratories Q2 Results FY27?

Ans. Divi's Laboratories Q2 Results FY27 are the quarterly results for July to September 2026, showing revenue of Rs 3,647 Cr. Alongside this, net profit came in at Rs 1,140 Cr, as set out in the Quick Answer.

What is the results date for Divi's Laboratories Q2 Results FY27?

Ans. Divi's Laboratories declared its Q2 FY27 results on 7 November 2026, which is the results date for the July to September quarter. This date is also stated in the opening paragraph of this article.

What revenue was reported in Divi's Laboratories Q2 Results FY27?

Ans. Divi's Laboratories reported revenue of Rs 3,647 Cr for Q2 FY27, compared with Rs 2,715 Cr a year earlier, as shown in the Financial Highlights table that follows the introduction.

What net profit was reported in Divi's Laboratories Q2 Results FY27?

Ans. Divi's Laboratories reported net profit of Rs 1,140 Cr in Q2 FY27, compared with Rs 689 Cr in the same quarter last year, as the Key Takeaways section lists it with its 65.46% rise.

How much YoY growth did revenue show in Divi's Laboratories Q2 Results FY27?

Ans. Revenue showed YoY growth of 34.33% in Divi's Laboratories Q2 Results FY27, moving from Rs 2,715 Cr to Rs 3,647 Cr, which the Performance Analysis section describes as a difference of Rs 932 Cr.

Did net profit rise or fall in Divi's Laboratories Q2 Results?

Ans. Net profit rose in Divi's Laboratories Q2 Results, by 65.46% YoY to Rs 1,140 Cr, while the net profit margin moved to 31.3% from 25.4%, a point covered in the Key Business Factors section.

What was the net profit margin in Divi's Laboratories Q2 Results FY27?

Ans. The net profit margin was 31.3% in Divi's Laboratories Q2 Results FY27, compared with 25.4% in the comparison quarter, which means profit grew faster than revenue, as the Performance Analysis section explains.

What was the return on equity around Divi's Laboratories Q2 Results FY27?

Ans. Return on equity was 16.19% in FY26, the latest full-year figure supplied alongside Divi's Laboratories Q2 Results FY27 and discussed in the Key Business Factors section of this article.

What business factors shaped Divi's Laboratories Q2 Results FY27?

Ans. Revenue growth of 34.3%, net profit growth of 65.5% and a margin of 31.3% were the three business factors listed for Divi's Laboratories Q2 Results FY27, as the Key Business Factors section details.

What are the key risks after Divi's Laboratories Q2 Results FY27?

Ans. The Key Risks section notes that one quarter does not set a trend and that return on equity is an annual figure rather than a quarterly one, so later filings carry the next comparison.

What is the outlook after Divi's Laboratories Q2 Results?

Ans. FY27 full-year results will depend on subsequent quarters and disclosed sector conditions, so Divi's Laboratories Q2 Results are one data point, and the FY27 Outlook section describes how later filings add comparisons.

Where can I find the complete Divi's Laboratories Q2 Results FY27 data?

Ans. The complete Divi's Laboratories Q2 Results FY27 figures sit in the Financial Highlights table above, while the Univest Screener lets you follow later filings and compare net profit trends in one place.